Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06294145 · ClinicalTrials.gov registry record · NA

Effects of a Wellbeing Intervention on Inflammation Through Reward and Threat Processes

A NA study of Low Positive Affect, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06294145 is a NA study of Low Positive Affect that has completed, run by University of California, Los Angeles. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06294145, a NA study of Low Positive Affect, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study aims to evaluate how savoring influences reward and threat processes and downstream inflammation. Savoring is designed to enhance positive affect, which may blunt stress responses and reduce downstream inflammation. The investigators aim to examine changes in the brain following the savoring intervention. The investigators are particularly interested in changes in brain activity that are correlated with changes in inflammation-related markers in the blood. In this single-armed pilot trial, the investigators will assess how savoring alters reactivity to rewarding and threatening experiences, and then examine related changes in downstream inflammation. The investigators intend to recruit 20 undergraduate students to complete a 7-week standardized savoring intervention. Participants will complete brain scans, daily diaries, questionnaires, a behavioral task, and blood collection at pre- and post-intervention assessments.

Conditions Studied

Interventions

  • BEHAVIORAL Savoring Intervention

Study Locations (1)

California

  • University of California, Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-02-07
Est. Completion 2025-05-01
Phase NA

What the Registry Record Tells You About NCT06294145

The ClinicalTrials.gov registry entry for NCT06294145 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Low Positive Affect appearing as the primary indexed condition, and to 1 intervention - of which Savoring Intervention is the first listed.

NCT06294145 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06294145 about?

NCT06294145 is a clinical study titled "Effects of a Wellbeing Intervention on Inflammation Through Reward and Threat Processes". This study aims to evaluate how savoring influences reward and threat processes and downstream inflammation. Savoring is designed to enhance positive affect, which may blunt stress responses and reduce downstream inflammation. The investigators aim to examine changes in the brain following the savor...

What is the current status of trial NCT06294145?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2024-02-07. Estimated completion is 2025-05-01.

What conditions does trial NCT06294145 study?

This clinical trial studies the following conditions: Low Positive Affect.

What interventions are being tested in trial NCT06294145?

The interventions under investigation include: Savoring Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06294145?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06294145 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.